Nursing interventions for managing treatment-related adverse effects of targeted anti-tumor therapies in adult cancer patients: a scoping review
Pflegeinterventionen zum Management behandlungsbedingter Nebenwirkungen zielgerichteter Antitumortherapien bei erwachsenen Krebspatient:innen: Scoping Review
Frontiers in Pharmacology · 20.10.2026 · 17
DOI: 10.3389/fphar.2026.1936674 ↗Auf einen Blick
14 Studien kartierten Pflegeinterventionen bei Nebenwirkungen zielgerichteter Antitumortherapien. Strukturierte pflegerische Maßnahmen waren mit geringerer Toxizität, besserer Adhärenz und höherer Lebensqualität verbunden.
Fragestellung
Welche pflegerischen Interventionen werden zur Prävention, Überwachung und Behandlung von Nebenwirkungen zielgerichteter Antitumortherapien bei erwachsenen Krebspatient:innen eingesetzt?
Methode
Scoping Review von englischsprachigen Studien aus 2015 bis 2025; deskriptive Synthese nach Interventionsart und Nebenwirkungsbereich.
Ergebnisse
14 Studien: 2 quasi-experimentelle Studien, 1 RCT-Protokoll, 2 Kohortenstudien, 7 narrative oder integrative Reviews und 2 klinische Leitlinien. 5 Interventionskategorien wurden identifiziert.
Schlussfolgerung der Autor:innen
Pflegegeleitete Interventionen könnten eine wichtige und vielversprechende Rolle für den sicheren und wirksamen Einsatz zielgerichteter Antitumortherapien bei Erwachsenen mit Krebs haben.
Kernaussagen
- Pflegeinterventionen wurden in 5 Kategorien geordnet.
- Strukturierte Maßnahmen senkten die Toxizitätslast.
- Adhärenz, Nutzung ungeplanter Versorgung und Lebensqualität verbesserten sich.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.10.2026. Verfasst von Omar Alqaisi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Nursing, Al-Zaytoonah University, Amman, Jordan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Targeted anti-tumor therapies, including tyrosine kinase inhibitors, antibody-drug conjugates, and immune checkpoint inhibitors, have improved clinical outcomes and survival across multiple cancers but are associated with clinically significant dermatologic, neurological, gastrointestinal, hematologic, and immune-related toxicities that compromise adherence and quality of life.
Objectives
This scoping review aimed to systematically map the available evidence on nursing interventions used to prevent, monitor, and manage adverse effects associated with targeted anti-tumor therapies in adult cancer patients.
Methods
Eligible studies were English-language publications conducted between 2015 and 2025 that focused on nurse-led or nursing-centered interventions addressing the adverse effects of targeted anti-tumor therapies in adult oncology populations. Data were charted using a standardized form and synthesized descriptively by intervention type and adverse-effect domain.
Results
Of 742 records identified, 14 studies met the inclusion criteria. Study designs included two quasi-experimental studies and one randomized controlled trial protocol two cohort studies, seven narrative or integrative reviews, and two clinical practice guidelines. Five principal intervention categories were identified: patient education and self-management support; nurse-led oral targeted-drug management and continuity-of-care programs; home-based multidisciplinary interventions; telephone and telehealth-based toxicity monitoring; and symptom-specific supportive-care strategies. Across diverse settings, structured nursing interventions reduced toxicity burden, improved medication adherence, decreased unplanned healthcare use, and enhanced patient-reported quality of life and psychosocial outcomes.
Conclusion
Nurse-led interventions may have an important and promising role in supporting the safe and effective use of targeted anti-tumor therapies in adults with cancer. Integrating structured education, continuity of care, multidisciplinary collaboration, and telehealth-enabled monitoring into routine oncology practice may optimize toxicity management and support treatment adherence. Further multicenter trials are needed to evaluate nursing protocols for antibody-drug conjugate-induced neuropathy and immune-related adverse events and to examine long-term clinical and economic outcomes. Systematic Review Registration https://osf.io/5nvfe/identifier , 5nvfe.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Nursing, Al-Zaytoonah University, Amman, Jordan.
- Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.
- Department of Nursing, Faculty of Nursing, Salina Regional Health Center: Salina, Salina, KS, United States.
Zitieren
APA
Alqaisi, O., Al-Ghabeesh, S., Dibas, M., Alwaqfi, Y., & Yaghmour, G. (2026). Nursing interventions for managing treatment-related adverse effects of targeted anti-tumor therapies in adult cancer patients: a scoping review. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1936674
Vancouver
Alqaisi O, Al-Ghabeesh S, Dibas M, Alwaqfi Y, Yaghmour G. Nursing interventions for managing treatment-related adverse effects of targeted anti-tumor therapies in adult cancer patients: a scoping review. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1936674
BibTeX
@article{Alqaisi2026,
author = {Alqaisi, Omar and Al-Ghabeesh, Suhair and Dibas, Mohammed and Alwaqfi, Yara and Yaghmour, Ghada},
title = {Nursing interventions for managing treatment-related adverse effects of targeted anti-tumor therapies in adult cancer patients: a scoping review},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1936674}
}
EUVIMED